Aegerion Pharmaceuticals, Inc. - FORM 10-K - EX-23.2 - CONSENT OF ERNST & YOUNG LLP - March 31, 2011

Attached files

file filename
EX-31.2 - CERTIFICATION OF PRESIDENT OF THE COMPANY PURSUANT TO SECTION 302 - Aegerion Pharmaceuticals, Inc.dex312.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - Aegerion Pharmaceuticals, Inc.dex211.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO SECTION 302 - Aegerion Pharmaceuticals, Inc.dex311.htm
10-K - FORM 10-K - Aegerion Pharmaceuticals, Inc.d10k.htm
EX-32.1 - CERTIFICATION OF CEO OF THE COMPANY PURSUANT TO SECTION 906 - Aegerion Pharmaceuticals, Inc.dex321.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-171341) pertaining to the 2006 Stock Option and Grant Plan, as amended and 2010 Stock Option and Incentive Plan of Aegerion Pharmaceuticals, Inc. of our report dated March 31, 2011, with respect to the financial statements of Aegerion Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

/s/ Ernst & Young, LLP

MetroPark, New Jersey

March 31, 2011

Aegerion Pharmaceuticals, Inc. Reports